CVE-2026-34323

Katalog CVE

CVSS 6.3 · Medium EPSS 0,24%

Kerentanan Improper Access Control pada oracle life sciences inform. Skor CVSS 3.1 6.3 (Medium) menurut oracle.com.

Deskripsi (NVD)

Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).

Rincian

Terbit di NVD

21 April 2026

Terakhir diubah

17 Juni 2026

Status NVD

Analyzed

CVSS 3.1

6.3 (Medium), sumber oracle.com
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L · uraikan di kalkulator

Jenis kelemahan (CWE)

CWE-284: Improper Access Control

EPSS (30 hari)

0,24% peluang dieksploitasi; lebih tinggi dari 14,0% CVE lain

Produk dan versi terdampak

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

• https://www.oracle.com/security-alerts/cpuapr2026.html advisory vendor